Company

Organogenesis Inc.

Organogenesis Inc. is a Canton, US regenerative medicine company offering advanced wound care and surgical products.

About

Founded in 1985 in Canton, US, Organogenesis Inc. focuses on regenerative medicine, with products such as Apligraf, PuraPly and the CYGNUS line for complex wounds, burns and surgical injuries, sold to hospitals, surgical centers and clinics. CEO Gary Gillheeney leads the company, which raised USD 450.00 mn in its IPO. In March 2019 it received a USD 100 mn credit facility from Silicon Valley Bank and MidCap Financial. The stage is Series C.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in